SA
ARGNF logo
argenx SE(ARGNF)
Closing price · checked 10:12 PM ETAbout this dataData status
$965.00▲0.00 (0.00%)
Extended:$965.00+0.00 (+0.00%)· 10:12 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

argenx SE (ARGNF)

Operating Expenses

$4.87B

TTM · Period ending: · USD

ARGNF logo

ARGNF Operating Expenses

Latest reported$4.87B
ARGNF Operating Expenses ($6.18M → $4.87B)
High-resolution chart · PNG

What is operating expenses?

Expenses from normal business operations (SG&A, R&D, etc.).

ARGNF operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

argenx SE Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)Change
2,648,202,000+33.44%
1,984,596,000+29.41%
1,533,530,000+39.20%
1,101,656,000+30.22%
846,023,000+63.05%
518,860,000+87.08%
277,354,000+134.65%
118,201,000+66.02%
71,198,742+87.38%
37,996,929+54.75%
24,554,479+39.27%
17,630,964+43.35%
12,299,428−20.53%
15,475,970+150.59%
6,175,879—

Frequently asked questions: ARGNF operating expenses

What is argenx SE (ARGNF)'s current operating expenses?

argenx SE (ARGNF)'s latest reported operating expenses (TTM) is $4.87B as of Sep 30, 2026. Expenses from normal business operations (SG&A, R&D, etc.).

How much historical operating expenses data is available for ARGNF?

Stock Alarm Pro provides 15 dated annual fiscal periods observations for argenx SE (ARGNF)'s operating expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare ARGNF's operating expenses to peers or set an alert?

You can open ARGNF's operating expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on ARGNF delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.